ZANUBRUTINIB
zanubrutinib 80 mg capsule, 120
ZANUBRUTINIB (13628G)
13628G
Manner of administration:Oral
Restriction
Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: First line drug treatment of this indication
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 120 | # of repeats: 5 | DPMQ: $7,932.89 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Brukinsa | |||||